Polymorphic, crystalline and mesophase forms of sodium 2- (5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3ylthio)acetate, and uses thereof

Details for Australian Patent Application No. 2011203708 (hide)

Owner Ardea Biosciences, Inc.

Inventors Zamansky, Irina; Galvin, Gabriel; Girardet, Jean-luc

Agent Shelston IP

Pub. Number AU-A-2011203708

PCT Pub. Number WO2011/085009

Priority 61/293,602 08.01.10 US

Filing date 5 January 2011

Wipo publication date 14 July 2011

International Classifications

C07D 249/12 Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

A61K 31/4196 - 1,2,4-Triazoles

A61P 13/00 Drugs for disorders of the urinary system

A61P 13/12 Drugs for disorders of the urinary system

Event Publications

26 July 2012 PCT application entered the National Phase

  PCT publication WO2011/085009 Priority application(s): WO2011/085009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011203712-Pressure release encoding system for communicating downhole information through a wellbore to a surface location

2011203707-Systems and methods for analyzing event data